MPH 515 Week 3 Study Design Critique Example

Study Design Critique: What the Massachusetts Naloxone Distribution Time Series Could and Could Not Establish About Overdose Deaths

Student Name

Chamberlain University

MPH 515: Epidemiology and Biostatistics for Public Health Application I

Instructor Name

Month Day, Year

Study Design Critique: What the Massachusetts Naloxone Distribution Time Series Could and Could Not Establish About Overdose Deaths

The Study and Why It Matters Here

Walley et al. (2013) examined whether state-supported overdose education and nasal naloxone distribution programs were followed by lower opioid overdose death rates in Massachusetts. The study matters for Bellamy County, the composite county used in this course, because its health department is considering expanding naloxone distribution from one pharmacy program to community sites, and the Massachusetts study is among the most cited pieces of evidence for doing so. This critique asks what the study's design allowed it to establish, who it included, how exposure and outcome were measured, which biases could have affected the result and in which direction, and what confounders remained.

The Design, Named and Defended

The authors describe the study as an interrupted time series analysis. Its unit of analysis was the community-year: 19 Massachusetts cities and towns, each observed annually from 2002 to 2009, classified each year by how intensively the program had been implemented: none, low (up to 100 enrollments per 100,000 residents) or high (above 100). The outcomes were annual opioid overdose death rates and acute care hospital use. Because exposure was measured for communities rather than individuals, the study is also ecological: it compares community rates, not the experiences of people who did or did not receive naloxone. Naming both features matters, because each sets limits on what the study can claim.

What the Design Could Establish

An interrupted time series compares outcomes before and after an intervention, using the earlier trend to estimate what would have happened without it. With comparison communities that did not implement the program, it can show whether communities with more implementation had lower death rates than expected, after adjusting for measured factors. Walley et al. (2013) found that, compared with communities with no implementation, death rates were lower in community-years with up to 100 enrollments for every 100,000 residents (adjusted rate ratio 0.73, 95% confidence interval 0.57 to 0.91) and lower still with more than 100 enrollments (0.54, 0.39 to 0.76), with no significant difference in acute care use. The gradient with intensity strengthens the case that the association is real.

What the design cannot establish is that naloxone distributed to individuals prevented those individuals' deaths. That would require individual-level data on who carried naloxone and who survived. The study shows that communities with more program activity had fewer deaths, which is consistent with the program's effect but does not prove the mechanism.

Who Took Part

The 19 communities were those with at least five fatal opioid overdoses in each year from 2004 to 2006. This selection made the study possible, since communities with few deaths would give unstable rates, but it also means the findings apply to communities with an established overdose problem. A county like Bellamy, with a high rate of nonfatal visits, fits that description, but smaller rural communities may not. Within communities, close to 3,000 potential bystanders went through training, and they later reported more than 300 rescues. Who enrolled was not random: people already in contact with services may have been more likely to enroll.

Measurement and Misclassification

Exposure was measured as program enrollments per 100,000 population, which captures program activity but not whether naloxone was carried or used during an overdose. Some misclassification is likely, and because enrollment counts were recorded the same way across communities, much of it may be nondifferential, which would tend to bias results toward finding no effect. Outcome measurement relied on death certificates, which are generally complete for deaths but can misclassify the drugs involved; changes in toxicology testing over the period could change how many deaths were coded as opioid related, independent of the program.

Bias, With a Direction

Three biases are worth stating with their likely direction. First, if communities that adopted the program early were also those investing in other overdose prevention, such as treatment expansion, the program's apparent effect would be biased away from the null, appearing larger than it was. Second, if the program was placed first in communities whose death rates were rising fastest, regression toward the mean could make later declines look like program effects, again biasing away from the null. Third, nondifferential misclassification of exposure would bias toward the null, making the true effect possibly larger. The net direction cannot be known from the paper, but the first two are the more serious threats because they could manufacture an effect.

Table 1

Threats to Validity and Their Likely Direction

Note. Note. Directions are the reviewer's judgment based on the study design.

Named Confounders

The authors adjusted for several community-level factors, including demographics and measures of treatment and prescribing, which strengthens the study. Confounders that could remain include changes in the illicit drug supply that differed between communities, local police or emergency medical service practices, and the availability of buprenorphine treatment, which reduces overdose risk and was expanding during the period. Any of these could differ between communities with high and low program activity.

Overall Judgment

The study provides good observational evidence that communities with naloxone distribution programs had lower opioid overdose death rates, with a dose-response gradient that supports a causal reading. It cannot establish individual-level effect and remains open to confounding by co-interventions and to regression to the mean. For Bellamy County, it supports expanding naloxone distribution as a reasonable, low-cost step, while a local evaluation should track individual reports of naloxone use and community death rates together, so that the county's own experience adds evidence rather than assuming the Massachusetts result transfers in full.

What a Local Evaluation Should Borrow

Three features of the Massachusetts design are worth copying in Bellamy County: comparing areas by intensity of program activity rather than by presence or absence alone, which allows a dose-response check; adjusting for treatment availability, which changes alongside naloxone programs; and reporting acute care use as well as deaths, since the two can move differently, as they did in Massachusetts.

References

Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ, 346, f174. https://doi.org/10.1136/bmj.f174